[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE04681B1 - 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon - Google Patents

3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon

Info

Publication number
EE04681B1
EE04681B1 EEP200000226A EEP200000226A EE04681B1 EE 04681 B1 EE04681 B1 EE 04681B1 EE P200000226 A EEP200000226 A EE P200000226A EE P200000226 A EEP200000226 A EE P200000226A EE 04681 B1 EE04681 B1 EE 04681B1
Authority
EE
Estonia
Prior art keywords
azalides
ketals
preparation
pharmaceutical composition
pharmaceutical
Prior art date
Application number
EEP200000226A
Other languages
English (en)
Inventor
Kobrehel Gabrijela
Lazarevski Gorjana
Vinkovic Mladen
Original Assignee
PLIVA, farmaceutska industrija, dionicko dru�tvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HR970551A external-priority patent/HRP970551B1/xx
Priority claimed from HR980497A external-priority patent/HRP980497B1/xx
Application filed by PLIVA, farmaceutska industrija, dionicko dru�tvo filed Critical PLIVA, farmaceutska industrija, dionicko dru�tvo
Publication of EE200000226A publication Critical patent/EE200000226A/et
Publication of EE04681B1 publication Critical patent/EE04681B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200000226A 1997-10-16 1998-10-13 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon EE04681B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HR970551A HRP970551B1 (en) 1997-10-16 1997-10-16 Novel o-methyl azythromycin derivatives
HR980497A HRP980497B1 (en) 1998-09-10 1998-09-10 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
PCT/HR1998/000005 WO1999020639A2 (en) 1997-10-16 1998-10-13 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES

Publications (2)

Publication Number Publication Date
EE200000226A EE200000226A (et) 2001-06-15
EE04681B1 true EE04681B1 (et) 2006-08-15

Family

ID=26317108

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000226A EE04681B1 (et) 1997-10-16 1998-10-13 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon

Country Status (26)

Country Link
US (1) US6369035B1 (et)
EP (2) EP1036083B9 (et)
JP (1) JP2001520234A (et)
KR (1) KR100554549B1 (et)
CN (1) CN1281615C (et)
AR (1) AR018014A1 (et)
AT (2) ATE348836T1 (et)
AU (1) AU755315B2 (et)
BG (1) BG64650B1 (et)
BR (1) BR9812808A (et)
CA (1) CA2306963C (et)
DE (2) DE69824201T2 (et)
DK (2) DK1036083T5 (et)
EE (1) EE04681B1 (et)
ES (2) ES2222610T3 (et)
HK (1) HK1032785A1 (et)
HU (1) HUP0004085A3 (et)
IL (2) IL135648A0 (et)
NO (1) NO20001871L (et)
NZ (1) NZ503897A (et)
PL (1) PL191087B1 (et)
PT (2) PT1437359E (et)
RU (1) RU2220148C2 (et)
SI (2) SI1036083T1 (et)
SK (1) SK285914B6 (et)
WO (1) WO1999020639A2 (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0104192A3 (en) * 1998-11-03 2003-12-29 Pfizer Prod Inc Novel macrolide antibiotics
KR100361397B1 (ko) * 2000-03-15 2002-11-23 한미약품공업 주식회사 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법
EP1482957A4 (en) 2002-02-15 2006-07-19 Merckle Gmbh ANTIBIOTIC CONJUGATES
EP1483277A4 (en) 2002-02-15 2007-10-03 Merckle Gmbh CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS OF PREPARATION AND USE, AND FORMULATION AND PHARMACEUTICAL APPLICATIONS
US20060099660A1 (en) 2002-02-15 2006-05-11 Synovo Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
HRP20020779A2 (en) 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
WO2004106353A1 (en) * 2003-05-30 2004-12-09 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
WO2008106204A1 (en) * 2007-02-28 2008-09-04 Rib-X-Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
US9145436B2 (en) 2010-10-10 2015-09-29 Michael W. Burnet Anti-inflammatory macrolides
CA2869461A1 (en) * 2012-03-27 2013-10-03 Michael W. BURNET Anti-inflammatory macrolides
JP7184520B2 (ja) * 2018-01-22 2022-12-06 旭化成株式会社 トランス型脂環式カーボネートの製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
DE3860503D1 (de) * 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
WO1999000124A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment

Also Published As

Publication number Publication date
BG64650B1 (bg) 2005-10-31
KR100554549B1 (ko) 2006-03-03
BR9812808A (pt) 2005-04-12
EP1437359A2 (en) 2004-07-14
WO1999020639A2 (en) 1999-04-29
ES2279242T3 (es) 2007-08-16
PT1437359E (pt) 2007-04-30
DE69836697T2 (de) 2007-10-04
BG104445A (en) 2001-02-28
HK1032785A1 (en) 2001-08-03
SK285914B6 (sk) 2007-11-02
KR20010031160A (ko) 2001-04-16
EP1437359A3 (en) 2005-03-30
ATE267835T1 (de) 2004-06-15
NO20001871L (no) 2000-04-17
DK1036083T5 (da) 2005-04-04
IL135648A0 (en) 2001-05-20
CA2306963C (en) 2007-05-01
EP1437359B1 (en) 2006-12-20
DK1036083T3 (da) 2004-09-27
AU755315B2 (en) 2002-12-12
IL135648A (en) 2007-03-08
RU2220148C2 (ru) 2003-12-27
DE69824201D1 (de) 2004-07-01
CN1281615C (zh) 2006-10-25
DK1437359T3 (da) 2007-04-30
EP1036083B9 (en) 2005-01-12
EE200000226A (et) 2001-06-15
SI1437359T1 (sl) 2007-06-30
NZ503897A (en) 2002-10-25
HUP0004085A2 (hu) 2001-04-28
SK5522000A3 (en) 2000-11-07
US6369035B1 (en) 2002-04-09
SI1036083T1 (en) 2004-10-31
NO20001871D0 (no) 2000-04-11
PL340372A1 (en) 2001-01-29
PL191087B1 (pl) 2006-03-31
WO1999020639A3 (en) 1999-07-08
JP2001520234A (ja) 2001-10-30
DE69824201T2 (de) 2005-09-22
HUP0004085A3 (en) 2003-05-28
PT1036083E (pt) 2004-10-29
EP1036083A2 (en) 2000-09-20
DE69836697D1 (de) 2007-02-01
CA2306963A1 (en) 1999-04-29
ATE348836T1 (de) 2007-01-15
AR018014A1 (es) 2001-10-31
CN1280585A (zh) 2001-01-17
AU9362298A (en) 1999-05-10
ES2222610T3 (es) 2005-02-01
EP1036083B1 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
EE200000319A (et) hGRF-PEG konjugaatide saitspetsiifiline valmistamismeetod, hGRF-PEG konjugaadid, nende vaheühendid, kasutamine ja farmatseutiline kompositsioon
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
EE03680B1 (et) Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
BR9509688A (pt) Composto e composição farmacêutica
EE04398B1 (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI973229A (fi) Uusi farmaseuttinen koostumus
BR9507768A (pt) Composição farmacêutica
FI960316A0 (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI953956A0 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
ID18698A (id) Komposisi farmasi
ITMI951417A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
EE9500029A (et) Farmatseutiline pihustatav kompositsioon ja selle saamise meetod
ITMI962628A0 (it) Composizione farmaceutica
EE9800085A (et) 3,5-difluoropüridiinid, nende valmistamismeetod, herbitsiidne kompositsioon ja nende kasutamine
NO306672B1 (no) N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081013